Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery

Dolastatin derivatives, represented by monomethylauristatin E (MMAE), have been translated in clinic with a form of antibody–drug conjugate; however, their potential in nanoparticle systems has not been well established due to the potential risk of immature release of extremely high cytotoxic dolast...

Full description

Bibliographic Details
Main Authors: Jihoon Kim, Jee Seon Kim, Kyung Hyun Min, Young-Hwa Kim, Xiaoyuan Chen
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/8/4/43
_version_ 1797539703152443392
author Jihoon Kim
Jee Seon Kim
Kyung Hyun Min
Young-Hwa Kim
Xiaoyuan Chen
author_facet Jihoon Kim
Jee Seon Kim
Kyung Hyun Min
Young-Hwa Kim
Xiaoyuan Chen
author_sort Jihoon Kim
collection DOAJ
description Dolastatin derivatives, represented by monomethylauristatin E (MMAE), have been translated in clinic with a form of antibody–drug conjugate; however, their potential in nanoparticle systems has not been well established due to the potential risk of immature release of extremely high cytotoxic dolastatin drugs during blood circulation. Herein, we rationally propose monomethylauristatin F (MMAF), a dolastatin-derived, loaded nanoparticle system composed of bombesin (BBN)-tethered ROS-responsive micelle system (BBN-PEG-PPADT) to achieve efficient anticancer therapy with targeted and efficient delivery of MMAF. The developed MMAF-loaded BBN-PEG-PPADT micelles (MMAF@BBN-PEG-PPADT) exhibited improved cellular uptake via interactions between BBN and gastrin-releasing peptide receptors on the cancer cells and the intracellular burst release of MMAF, owing to the ROS-responsive disruption, which allowed the efficient anticancer effects of MMAF in vitro. This study suggests the potential of nanoparticle systems in the delivery of dolastatin drugs.
first_indexed 2024-03-10T12:49:36Z
format Article
id doaj.art-b9fb317cd87d49f383b31ccefd17b2ad
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-10T12:49:36Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-b9fb317cd87d49f383b31ccefd17b2ad2023-11-21T13:13:34ZengMDPI AGBioengineering2306-53542021-03-01844310.3390/bioengineering8040043Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) DeliveryJihoon Kim0Jee Seon Kim1Kyung Hyun Min2Young-Hwa Kim3Xiaoyuan Chen4Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, 315 Ferst Dr NW, Atlanta, GA 30332, USALG Chem, Seoul 07336, KoreaDepartment of Pharmacy, School of Pharmacy, Jeonbuk National University, Jeonju 54896, KoreaMechanical Design Engineering, Jeonbuk National University, Jeonju 54896, KoreaYong Loo Lin School of Medicine and Faculty of Engineering, National University of Singapore, Singapore 117597, SingaporeDolastatin derivatives, represented by monomethylauristatin E (MMAE), have been translated in clinic with a form of antibody–drug conjugate; however, their potential in nanoparticle systems has not been well established due to the potential risk of immature release of extremely high cytotoxic dolastatin drugs during blood circulation. Herein, we rationally propose monomethylauristatin F (MMAF), a dolastatin-derived, loaded nanoparticle system composed of bombesin (BBN)-tethered ROS-responsive micelle system (BBN-PEG-PPADT) to achieve efficient anticancer therapy with targeted and efficient delivery of MMAF. The developed MMAF-loaded BBN-PEG-PPADT micelles (MMAF@BBN-PEG-PPADT) exhibited improved cellular uptake via interactions between BBN and gastrin-releasing peptide receptors on the cancer cells and the intracellular burst release of MMAF, owing to the ROS-responsive disruption, which allowed the efficient anticancer effects of MMAF in vitro. This study suggests the potential of nanoparticle systems in the delivery of dolastatin drugs.https://www.mdpi.com/2306-5354/8/4/43auristatin drugsMMAFbombesinreactive oxygen species-responsivedrug delivery
spellingShingle Jihoon Kim
Jee Seon Kim
Kyung Hyun Min
Young-Hwa Kim
Xiaoyuan Chen
Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
Bioengineering
auristatin drugs
MMAF
bombesin
reactive oxygen species-responsive
drug delivery
title Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
title_full Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
title_fullStr Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
title_full_unstemmed Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
title_short Bombesin-Tethered Reactive Oxygen Species (ROS)-Responsive Nanoparticles for Monomethyl Auristatin F (MMAF) Delivery
title_sort bombesin tethered reactive oxygen species ros responsive nanoparticles for monomethyl auristatin f mmaf delivery
topic auristatin drugs
MMAF
bombesin
reactive oxygen species-responsive
drug delivery
url https://www.mdpi.com/2306-5354/8/4/43
work_keys_str_mv AT jihoonkim bombesintetheredreactiveoxygenspeciesrosresponsivenanoparticlesformonomethylauristatinfmmafdelivery
AT jeeseonkim bombesintetheredreactiveoxygenspeciesrosresponsivenanoparticlesformonomethylauristatinfmmafdelivery
AT kyunghyunmin bombesintetheredreactiveoxygenspeciesrosresponsivenanoparticlesformonomethylauristatinfmmafdelivery
AT younghwakim bombesintetheredreactiveoxygenspeciesrosresponsivenanoparticlesformonomethylauristatinfmmafdelivery
AT xiaoyuanchen bombesintetheredreactiveoxygenspeciesrosresponsivenanoparticlesformonomethylauristatinfmmafdelivery